Journal of Aerosol Medicine and Pulmonary Drug Delivery

Papers
(The TQCC of Journal of Aerosol Medicine and Pulmonary Drug Delivery is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The Effect of Different Interfaces on the Aerosol Delivery with Vibrating Mesh Nebulizer During Noninvasive Positive Pressure Ventilation30
Fine Particle Fraction: The Good and the Bad21
Inhaled Nanoparticulate Systems: Composition, Manufacture and Aerosol Delivery20
Pressure Drop Characteristics of the Reduced NGI Configuration with Several Common Glass Fiber Filters19
Minimizing Aerosol Leakage from Facemasks in the COVID-19 Pandemic19
Feasibility and Initial Safety Evaluation of Inhaled 13C-Urea in Ambulatory Patients with Pneumonia19
Dry Powder Inhalers: From Bench to Bedside19
Suitability of Bronchoscopic Spraying for Fluid Deposition in Lower Airway Regions: Fluorescence Analysis on a Transparent In Vitro Airway Model17
Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action14
Abstract Author Indexby abstract number13
In Vitro Effect of Combined Hypertonic Saline and Salbutamol on Ciliary Beating Frequency and Mucociliary Transport in Human Nasal Epithelial Cells of Healthy Volunteers and Patients with Cysti11
Abstracts from The International Society for Aerosols in Medicine 23rd ISAM Congress Boise, Idaho May 22–26, 202111
Are the Reference Values for the Provocative Concentration of Methacholine Appropriate for Children?11
Rosalind Franklin Society Proudly Announces the 2022 Award Recipient for Journal of Aerosol Medicine and Pulmonary Drug Delivery10
An Investigation into the Factors Associated with Incorrect Use of a Pressurized Metered-Dose Inhaler in Japanese Patients10
Pharmaceutical, Clinical, and Regulatory Challenges of Reformulating Pressurized Metered-Dose Inhalers to Reduce Their Environmental Impact9
Imaging Aerosol Deposition with Two-Dimensional Gamma Scintigraphy8
In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles8
Developing Dry Powder Inhaler Formulations8
Optimal Inhalation Profile of Pressurized Metered Dry Powder Inhaler Using a Valved Holding Chamber: A Dynamic Analysis8
Heterogenous Intrapulmonary Distribution of Aerosolized Model Compounds in Mice with Bleomycin-Induced Pulmonary Fibrosis7
Spacers and Valved Holding Chambers7
Building on Strong Foundations: The Next Chapter in the Story of the Journal of Aerosol Medicine and Pulmonary Drug Delivery7
The Unfulfilled Promise of Inhaled Therapy in Ventilator-Associated Infections: Where Do We Go from Here?6
A Phase I Study of TRK-250, a Novel siRNA-Based Oligonucleotide, in Patients with Idiopathic Pulmonary Fibrosis6
Nebulizers6
Multidrug Aerosol Delivery During Mechanical Ventilation5
The Effects of Inspiratory Flows, Inspiratory Pause, and Suction Catheter on Aerosol Drug Delivery with Vibrating Mesh Nebulizers During Mechanical Ventilation5
Practical Considerations in Dose Extrapolation from Animals to Humans5
Inhalation Pharmacodynamics5
Safety and Efficacy of 2.5 mg and 1.25 mg Nebulized Salbutamol Compared with Placebo on Transient Tachypnea of the Newborns: A Triple-Blind Phase II/III Parallel Randomized Controlled Trial5
Abstract Author Index5
Inhaled Nitric Oxide in Acute Respiratory Distress Syndrome Subsets: Rationale and Clinical Applications5
Inspiratory Profiles Through Easyhaler Dry Powder Inhaler During Acute Bronchoconstriction4
How Cold Is Cold Enough? Refrigeration of the Next-Generation Impactor to Prevent Aerosol Undersizing4
Barriers that Inhaled Particles Encounter4
Pressurized Metered Dose Inhaler Aerosol Delivery Within Nasal High-Flow Circuits: A Bench Study4
Results of Tobramycin Inhalation Therapy in Patients with Noncystic Fibrosis Bronchiectasis with Pseudomonas aeruginosa Colonization: Real Life Management4
Spray Drying and Particle Engineering in Dosage Form Design for Global Vaccines4
Changes in Peak Inspiratory Flow After Acute Bronchodilation: An Observational Study of Patients with Stable Chronic Obstructive Pulmonary Disease4
Overview of Inhaled Nanopharmaceuticals4
In Vitro Drug Delivery of a Fixed-Dose Combination of Fluticasone Furoate/Umeclidinium/Vilanterol from a Dry Powder Inhaler4
Acknowledgment of Reviewers 20214
0.19092011451721